Acton, Massachusetts, April 3, 2024–(BUSINESS WIRE)–Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), a global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announces first quarter financial results. The plan has been announced. May 9, 2024, after the close of financial markets in 2024. In connection with this release, management will hold a conference call on the same day at 4:30 p.m. ET.
A link to the live call is available under “Events and Presentations'' in the Investor Information section of our website at Investors.insulet.com and will be archived for future playback. You can also access the live call by dialing (888) 770-7129 for domestic callers or (929) 203-2109 for international callers. Passcode is 5904836.
About Insulet Co., Ltd.:
Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying the lives of people with diabetes and other diseases through its Omnipod product platform. The Omnipod insulin management system provides a unique alternative to traditional insulin administration methods. With a simple, wearable design, the tubeless disposable pod provides up to 3 days of non-stop insulin delivery without the need to see or handle needles. Insulet's flagship innovation, the Omnipod®5 automatic insulin delivery system, is integrated with a continuous blood glucose monitor to help you manage your blood sugar levels without multiple daily injections or fingersticks, and can be used with a compatible personal smartphone or Fully controlled with Omnipod 5 controller. Insulet also leverages the pod's unique design by tailoring the Omnipod technology platform to deliver non-insulin subcutaneous medications across other treatment areas. For more information, visit insulet.com and omnipod.com.
©2024 Insulet Corporation. Omnipod is a registered trademark of Insulet Corporation. All rights reserved.
View source version on businesswire.com. https://www.businesswire.com/news/home/20240403888119/en/
contact address
Public relations activities for investors:
Deborah R. Gordon
Vice President of Investor Relations
(978) 600-7717
dgordon@insulet.com
media:
Angela Gelyak Wiczek
Senior Director of Corporate Communications
(978) 932-0611
awiczek@insulet.com
